Literature DB >> 25624340

Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.

Takeshi Matsumoto1, Kenji Oki1, Masato Kajikawa1, Ayumu Nakashima1, Tatsuya Maruhashi1, Yumiko Iwamoto1, Akimichi Iwamoto1, Nozomu Oda1, Takayuki Hidaka1, Yasuki Kihara1, Nobuoki Kohno1, Kazuaki Chayama1, Chikara Goto1, Yoshiki Aibara1, Kensuke Noma1, James K Liao1, Yukihito Higashi2.   

Abstract

The purpose of this study was to evaluate vascular function and activity of Rho-associated kinases (ROCKs) in patients with primary aldosteronism. Vascular function, including flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation, and ROCK activity in peripheral leukocytes were evaluated in 21 patients with aldosterone-producing adenoma (APA), 23 patients with idiopathic hyperaldosteronism (IHA), and 40 age-, sex-, and blood pressure-matched patients with essential hypertension (EHT). FMD was significantly lower in the APA group than in the IHA and EHT groups (3.2±2.0% versus 4.6±2.3% and 4.4±2.2%; P<0.05, respectively), whereas there was no significant difference in FMD between the IHA and EHT groups. There was no significant difference in nitroglycerine-induced vasodilation in the 3 groups. ROCK activity was higher in the APA group than in the IHA and EHT groups (1.29±0.57 versus 1.00±0.46 and 0.81±0.36l; P<0.05, respectively), whereas there was no significant difference in ROCK activity between the IHA and EHT groups. FMD correlated with age (r=-0.31; P<0.01), plasma aldosterone concentration (r=-0.35; P<0.01), and aldosterone:renin ratio (r=-0.34; P<0.01). ROCK activity correlated with age (r=-0.24; P=0.04), plasma aldosterone concentration (r=0.33; P<0.01), and aldosterone:renin ratio (r=0.46; P<0.01). After adrenalectomy, FMD and ROCK activity were restored in patients with APA. APA was associated with both endothelial dysfunction and increased ROCK activity compared with those in IHA and EHT. APA may have a higher risk of future cardiovascular events.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Rho-associated kinases; aldosterone; hyperaldosteronism; hypertension

Mesh:

Substances:

Year:  2015        PMID: 25624340      PMCID: PMC4917381          DOI: 10.1161/HYPERTENSIONAHA.114.05001

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

1.  Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences.

Authors:  David Sanz-Rosa; M Pilar Oubiña; Eva Cediel; Natalia De las Heras; Paloma Aragoncillo; Gloria Balfagón; Victoria Cachofeiro; Vicente Lahera
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

2.  Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase.

Authors:  M Amano; K Chihara; K Kimura; Y Fukata; N Nakamura; Y Matsuura; K Kaibuchi
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

3.  Excess norepinephrine impairs both endothelium-dependent and -independent vasodilation in patients with pheochromocytoma.

Authors:  Yukihito Higashi; Shota Sasaki; Keigo Nakagawa; Masashi Kimura; Satoshi Sasaki; Kensuke Noma; Hideo Matsuura; Keiko Hara; Chikara Goto; Tetsuya Oshima; Kazuaki Chayama
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

4.  Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.

Authors:  N Fujimura; K Noma; T Hata; J Soga; T Hidaka; N Idei; Y Fujii; S Mikami; T Maruhashi; Y Iwamoto; Y Kihara; K Chayama; H Kato; J K Liao; Y Higashi
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

Review 5.  Role of endothelium in responses of vascular smooth muscle.

Authors:  R F Furchgott
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

Review 6.  Mechanisms of mineralocorticoid action.

Authors:  Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

7.  Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide.

Authors:  Y Higashi; S Sasaki; S Kurisu; A Yoshimizu; N Sasaki; H Matsuura; G Kajiyama; T Oshima
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

8.  Possible involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell remodeling.

Authors:  Kayoko Miyata; Hirofumi Hitomi; Peng Guo; Guo-Xing Zhang; Shoji Kimura; Hideyasu Kiyomoto; Naohisa Hosomi; Shoji Kagami; Masakazu Kohno; Akira Nishiyama
Journal:  Hypertens Res       Date:  2008-07       Impact factor: 3.872

9.  Endothelial function and oxidative stress in renovascular hypertension.

Authors:  Yukihito Higashi; Shota Sasaki; Keigo Nakagawa; Hideo Matsuura; Tetsuya Oshima; Kazuaki Chayama
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

10.  Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.

Authors:  E L Schiffrin; L Y Deng
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

View more
  14 in total

1.  Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.

Authors:  Shinji Kishimoto; Kenji Oki; Tatsuya Maruhashi; Masato Kajikawa; Shogo Matsui; Haruki Hashimoto; Yuji Takaeko; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Yoshiki Aibara; Farina Mohamad Yusoff; Ayumu Nakashima; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

2.  Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.

Authors:  Yuta Nanao; Kenji Oki; Kazuhiro Kobuke; Kiyotaka Itcho; Ryuta Baba; Takaya Kodama; Yu Otagaki; Akira Okada; Yoko Yoshii; Gaku Nagano; Haruya Ohno; Koji Arihiro; Celso E Gomez-Sanchez; Noboru Hattori; Masayasu Yoneda
Journal:  Mol Cell Endocrinol       Date:  2022-03-04       Impact factor: 4.369

3.  Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.

Authors:  Yoko Yoshii; Kenji Oki; Celso E Gomez-Sanchez; Haruya Ohno; Kiyotaka Itcho; Kazuhiro Kobuke; Masayasu Yoneda
Journal:  Hypertension       Date:  2016-10-17       Impact factor: 10.190

4.  YPEL4 modulates HAC15 adrenal cell proliferation and is associated with tumor diameter.

Authors:  Kenji Oki; Maria W Plonczynski; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2016-06-19       Impact factor: 4.102

5.  Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction.

Authors:  Ahmet Demirkiran; Henk Everaars; Ali Elitok; Peter M van de Ven; Yvo M Smulders; Koen M Dreijerink; Refik Tanakol; Mustafa Ozcan
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-12       Impact factor: 3.738

Review 6.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

7.  Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.

Authors:  Miaomiao Sang; Yu Fu; Chenmin Wei; Jing Yang; Xueting Qiu; Jingqing Ma; Chao Qin; Feiyan Wu; Xueling Zhou; Tao Yang; Min Sun
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

Review 8.  Thoracic Aortic Aneurysm Development in Patients with Bicuspid Aortic Valve: What Is the Role of Endothelial Cells?

Authors:  Vera van de Pol; Kondababu Kurakula; Marco C DeRuiter; Marie-José Goumans
Journal:  Front Physiol       Date:  2017-11-30       Impact factor: 4.566

9.  Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Marko Poglitsch; Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Stefan Zorad; Michaela Adamcova; Ludovit Paulis
Journal:  Int J Mol Sci       Date:  2018-10-03       Impact factor: 5.923

10.  Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.

Authors:  Kuan-Ming Chen; Bo-Ching Lee; Po-Ting Chen; Kao-Lang Liu; Kuan-Heng Lin; Chin-Chen Chang; Tung-Hsin Wu; Jia-Sheng Hong; Yen-Hung Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.